Elsohly Laboratories, Inc.

Oxford, MS 38655

SBIR Award Summary

Total Number of Awards 17
Total Value of Awards $2.71MM
First Award Date 09/30/86
Most Recent Award Date 08/02/13

Key Personnel

Last Name Name Awards Contact
Elsohly Mahmoud A Elsohly 15
Clark Alice M. Clark 1
Feng Shixia Feng 1
Majumdar Soumyajit Majumdar 1

17 Awards Won

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-12-089
Budget: 08/02/13 - 07/31/14

DESCRIPTION (provided by applicant): The natural product artemisinin is a sesquiterpene endoperoxide with known anti-malarial activity against both chloroquine-sensitive and chloroquine-resistant strains of the parasite Plasmodium falciparum. In addition to its anti-malarial activity, artemisinin was reported to have cytotoxic activity against s...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-10-051
Budget: 03/01/11 - 02/28/13

DESCRIPTION (provided by applicant): Currently, FDA approved clinical applications of 9-Tetrahydrocannabinol (THC) include control of nausea and vomiting associated with chemotherapy and for appetite stimulation for AIDS patients suffering from anorexia and wasting syndrome. However, THC also has significant potential in the treatment of gla...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-08-051
Budget: 09/01/10 - 08/31/12

DESCRIPTION (provided by applicant): Poison ivy/oak contact dermatitis is the most prevalent skin allergy in the United States, affecting >50% of the adult population. The condition is the major cause of occupational hazard among outdoor workers in forestry, agriculture and firefighting, resulting in significant medical expenses and workers dis...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-08-051
Budget: 09/07/09 - 08/31/10

DESCRIPTION (provided by applicant): Poison ivy/oak contact dermatitis is the most prevalent skin allergy in the United States, affecting >50% of the adult population. The condition is the major cause of occupational hazard among outdoor workers in forestry, agriculture and firefighting, resulting in significant medical expenses and workers dis...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-07-281
Budget: 06/01/09 - 05/31/12

DESCRIPTION (provided by applicant): Delta-9-Tetrahydrocannabinol (THC), the active ingredient in the cannabis plant, has a wide range of pharmacological properties of therapeutic value. The drug has been approved by the Food and Drug Administration (FDA) (Marinol(r) soft gelatin capsules) for the treatment of nausea and vomiting associated with...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-07-281
Budget: 06/01/09 - 05/31/12

DESCRIPTION (provided by applicant): Delta-9-Tetrahydrocannabinol (THC), the active ingredient in the cannabis plant, has a wide range of pharmacological properties of therapeutic value. The drug has been approved by the Food and Drug Administration (FDA) (Marinol(r) soft gelatin capsules) for the treatment of nausea and vomiting associated with...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-07-81
Budget: 06/01/08 - 05/31/09

DESCRIPTION (provided by applicant): Delta-9-Tetrahydrocannabinol (THC), the active ingredient in the cannabis plant, has a wide range of pharmacological properties of therapeutic value. The drug has been approved by the Food and Drug Administration (FDA) (Marinol(r) soft gelatin capsules) for the treatment of nausea and vomiting associated with...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/06 - 07/31/07

DESCRIPTION (provided by applicant): The long term objectives of this proposal are aimed at the development of new composition(s) to be used for the prophylactic treatment/prevention of poison ivy contact dermatitis in sensitive individuals. Poison ivy/poison oak and another related species poison sumac are the main cause of occupational hazards...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/03 - 06/30/04

DESCRIPTION (provided by applicant): The overall goal of this research project is to develop an effective, hot-melt extruded "Transmucosal Matrix Patch" (TMP) as a delivery system for Delta-9-Tetrahydrocannabinol (THC). THC will be incorporated into a stable, bioadhesive drug delivery system that is applied to a subject's buccal or labial oral m...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/02 - 11/30/02

The development of maintenance treatment for subjects with addictive behavior is an important public health issue. Buprenorphine, a promising new drug for the treatment of opiates addition, has been widely abused since the mid-90's. Using drug testing for buprenorphine will become an important issue. The proposed research will focus on the prepa...

Load More